InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by McGaughy R Kent Jr, Director. Insider active across 5 companies, notably Apollo Endosurgery, Inc.. Aggregated, 11 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €259k. Activity tracked since 15 October 2021. The latest transaction was disclosed on 3 May 2024 (J). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to McGaughy R Kent Jr
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
1,785,127 shares0Common StockSEC:0000905148-24-001300:0
25,004 sharesClass A common stockSEC:0000905148-23-001010:0
675,181 sharesCommon StockSEC:0001140361-23-016441:0
33,217 shares0Class A common stockSEC:0001140361-23-010508:0
146,577 shares@ US$3.2546.4% of flowClass A common stockSEC:0001140361-22-047719:0
1,726,534 shares0Common StockSEC:0001140361-22-044739:0
1,729,482 shares0Common StockSEC:0001140361-22-041922:0
986,640 shares0Common StockSEC:0001140361-22-033193:0
743,021 shares0Common StockSEC:0001140361-22-032770:0
260,323 shares0Common StockSEC:0001567619-22-007150:0
38,710 shares@ US$7.7536.6% of flowClass A common stockSEC:0001140361-21-034925:0
Canonical exit: 13 Jan 2022 (T+90)
11 of 11 declarations
About McGaughy R Kent Jr
McGaughy R Kent Jr is Administrateur and has 11 filings in total. Across the 11 sampled filings, buys amount to EUR 258812 and sells to EUR 0, with a date range from 2021-10-19 to 2024-05-07. The companies mentioned in these filings are PROCEPT BioRobotics Corp, Apollo Endosurgery, Inc., Reata Pharmaceuticals INC, and Instil Bio, Inc.
